Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action inhibitors |
Mechanism SGK3 inhibitors(serum/glucocorticoid regulated kinase family member 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC59H77FN10O12S2 |
InChIKeyVRPWBMZBYLPNEA-XFFPAYIQSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | United Kingdom | 28 Aug 2019 | |
Breast Cancer | Preclinical | United Kingdom | 28 Aug 2019 |